{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:45:40Z","timestamp":1791276340249,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0095462","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T20:53:37Z","timestamp":1398200017000},"page":"e95462","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices"],"prefix":"10.1371","volume":"9","author":[{"given":"Inge M.","family":"Westra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorenda","family":"Oosterhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geny M. M.","family":"Groothuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Olinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"V Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"D Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: Nearing the starting line","volume":"5","author":"SL Friedman","year":"2013","journal-title":"Sci Transl Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"SL Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/labinvest.2009.77","article-title":"Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787\/ZK22258","volume":"89","author":"Y Liu","year":"2009","journal-title":"Lab Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"D Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"J Andrae","year":"2008","journal-title":"Genes Dev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"JC Bonner","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-beta in progression of liver disease","volume":"347","author":"S Dooley","year":"2012","journal-title":"Cell Tissue Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/00498254.2012.723151","article-title":"Evaluation of fibrosis in precision-cut tissue slices","volume":"43","author":"IM Westra","year":"2012","journal-title":"Xenobiotica"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/nprot.2010.111","article-title":"Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies","volume":"5","author":"IA de Graaf","year":"2010","journal-title":"Nat Protoc"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jhep.2013.01.009","article-title":"Precision-cut liver slices: A tool to model the liver ex vivo","volume":"58","author":"P Olinga","year":"2013","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/toxsci\/kfi127","article-title":"Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu","volume":"85","author":"M van de Bovenkamp","year":"2005","journal-title":"Toxicol Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.taap.2013.11.017","article-title":"Precision-cut liver slices as a model for the early onset of liver fibrosis to test anti-fibrotic drugs","volume":"274","author":"IM Westra","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2006.04.009","article-title":"Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro","volume":"45","author":"M van de Bovenkamp","year":"2006","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"G907","DOI":"10.1152\/ajpgi.00420.2004","article-title":"Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats","volume":"288","author":"H Yoshiji","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Wang Y, Gao J, Zhang D, Zhang J, Ma J, <etal>et al<\/etal>.. (2010) New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol.","DOI":"10.1016\/j.jhep.2010.02.027"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/hep.21921","article-title":"Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats","volume":"46","author":"S Tugues","year":"2007","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1478-3231.2005.01038.x","article-title":"Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development","volume":"25","author":"H Yoshiji","year":"2005","journal-title":"Liver International"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.23334","article-title":"Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo","volume":"51","author":"I Mannaerts","year":"2010","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.phymed.2009.05.002","article-title":"In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis","volume":"17","author":"GS Li","year":"2010","journal-title":"Phytomedicine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0168-8278(02)00245-3","article-title":"Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production","volume":"37","author":"A Di Sario","year":"2002","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0168-8278(02)00272-6","article-title":"Pirfenidone effectively reverses experimental liver fibrosis","volume":"37","author":"L Garcia","year":"2002","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1746.2006.04361.x","article-title":"Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis","volume":"22","author":"Y Hsu","year":"2007","journal-title":"J Gastroen Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbi.2003.10.005","article-title":"Effects of colchicine on liver functions of cirrhotic rats: Beneficial effects result from stellate cell inactivation and inhibition of TGF beta1 expression","volume":"147","author":"SJ Lee","year":"2004","journal-title":"Chem Biol Interact"},{"key":"ref26","first-page":"305","article-title":"Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat","volume":"65","author":"J Kountouras","year":"1984","journal-title":"Br J Exp Pathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/352760006X.ch12","article-title":"Use of human tissue slices in drug targeting research","volume":"12","author":"P Olinga","year":"2001","journal-title":"Drug Targeting: Organ-Specific Strategies"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"OH Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.LAB.0000054178.01162.E4","article-title":"The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis","volume":"83","author":"N Kinnman","year":"2003","journal-title":"Lab Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.06.015","article-title":"Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term","volume":"44","author":"M Neef","year":"2006","journal-title":"J Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"M Mejias","year":"2009","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Hennenberg M, Trebicka J, Kohistani Z, Stark C, Nischalke HD, <etal>et al<\/etal>.. (2010) Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis. Lab Invest.","DOI":"10.1038\/labinvest.2010.148"},{"key":"ref33","first-page":"899","article-title":"Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats","volume":"17","author":"H Yoshiji","year":"2006","journal-title":"Int J Mol Med"},{"key":"ref34","first-page":"857","article-title":"Preventative and therapeutic effects of perindopril on hepatic fibrosis induced by bile duct ligation in rats","volume":"2","author":"M Yeki","year":"2009","journal-title":"Mol Med Report"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0887-2333(91)90018-9","article-title":"Toxicity of valproic acid in liver slices from sprague-dawley rats and domestic pigs","volume":"5","author":"R Fisher","year":"1991","journal-title":"Toxicol In Vitro"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Ikura Y, Iwasa Y, Ueda M (2010) Valproic acid administration for hepatic fibrosis: A balance between antifibrotic efficacy and hepatotoxicity. Hepatology 51: 2227\u20138; author reply 2228.","DOI":"10.1002\/hep.23688"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1139\/y06-050","article-title":"Anti-fibrotic effects of tetrandrine on bile-duct ligated rats","volume":"84","author":"Y Hsu","year":"2006","journal-title":"Can J Physiol Pharm"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1034\/j.1600-0773.2000.pto870604.x","article-title":"Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats","volume":"87","author":"PH Park","year":"2000","journal-title":"Pharmacol Toxicol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2008.06.110","article-title":"Potent antioxidant role of pirfenidone in experimental cirrhosis","volume":"595","author":"A Salazar-Montes","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/newbio238257a0","article-title":"Microtubules in transcellular movement of procollagen","volume":"238","author":"HP Ehrlich","year":"1972","journal-title":"Nat New Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0168-8278(05)80181-3","article-title":"Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation","volume":"19","author":"JL Poo","year":"1993","journal-title":"J Hepatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/(SICI)1099-1263(199605)16:3<269::AID-JAT346>3.0.CO;2-Y","article-title":"Comparative study of colchicine and trimethylcolchicinic acid on prolonged bile duct obstruction in the rat","volume":"16","author":"V Castro","year":"1996","journal-title":"J Appl Toxicol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1034\/j.1600-0676.2003.00837.x","article-title":"Fibrosis and glycogen stores depletion induced by prolonged biliary obstruction in the rat are ameliorated by metadoxine","volume":"23","author":"P Muriel","year":"2003","journal-title":"Liver Int"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.bi.64.070195.002155","article-title":"Collagens: Molecular biology, diseases, and potentials for therapy","volume":"64","author":"DJ Prockop","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-61779-445-2_21","article-title":"Analysis of hydroxyproline in collagen hydrolysates","volume":"828","author":"T Langrock","year":"2012","journal-title":"Methods Mol Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0095462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:25:37Z","timestamp":1648869937000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0095462"}},"subtitle":[],"editor":[{"given":"Rifaat","family":"Safadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0095462","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,22]]}}}